AMBYLU LTD

Company number 12810112 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

AMBYLU LTD - Analysis Report

Company Number: 12810112

Analysis Date: 2025-07-19 12:56 UTC

Financial Health Assessment for AMBYLU LTD


1. Financial Health Score: Grade D

Explanation:
AMBYLU LTD is classified as a dormant company with minimal financial activity. Its financial "vital signs" show virtually no operational or transactional movement, reflected in its balance sheet showing net assets and shareholders' funds of just £1 (the nominal share capital). While this status carries no immediate distress, the lack of active trading or financial data means the company cannot be rated as financially healthy or robust. Dormancy is akin to a patient in a medically induced rest state: stable but inactive, with no signs of growth or stress.


2. Key Vital Signs:

  • Company Status: Active but Dormant (no significant transactions)
  • Turnover & Profit: £0 (no trading activity)
  • Net Assets: £1 (solely issued share capital)
  • Shareholders' Funds: £1 (equity equals nominal capital)
  • Filing Compliance: Up to date (no overdue accounts or returns)
  • Director: Single director, no known disqualifications or PSCs
  • Industry: Printing not elsewhere classified (SIC 18129) – no trading yet reported
  • Liquidity & Solvency: Not applicable due to dormancy; no liabilities or assets beyond share capital

Interpretation:
The company shows no financial activity or operational footprint. The balance sheet is essentially a snapshot of incorporation status without financial substance. Filing compliance is good, which is positive for regulatory health.


3. Diagnosis:

AMBYLU LTD currently exhibits a state of financial dormancy—no active business operations, no revenue, and virtually no assets or liabilities. This is not a symptom of distress but rather a deliberate or circumstantial pause in business activity. Without trading, there are no cash flows, profits, or working capital to evaluate. The company's financial health is stable but inert; it is like a patient in remission, neither improving nor deteriorating.


4. Recommendations:

  • Assess Business Intentions: If the company plans to commence trading, prepare for initial capital infusion, working capital requirements, and financial record-keeping systems.
  • Maintain Compliance: Continue timely filing of dormant accounts and confirmation statements to avoid penalties.
  • Financial Planning: Before trading starts, develop a realistic budget and cash flow forecast to ensure healthy liquidity and avoid symptoms of financial distress.
  • Director Oversight: The director should monitor any changes in company activity status and update records accordingly.
  • Consider Alternatives: If the company is not planned to trade, consider formal closure or preserving dormant status to minimize ongoing obligations.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.